(Q46300936)

21 December 2017

title

Memory in individuals with mild cognitive impairment in relation to APOE and CSF Abeta42. (English)

1 reference

21 December 2017

mild cognitive impairment

main subject

1 reference

inferred from title

cognitive dysfunction

1 reference

5

Henrik Zetterberg

1 reference

21 December 2017

4

Kaj Blennow

1 reference

21 December 2017

3

Ivar Reinvang

1 reference

21 December 2017

7

Boo Johansson

1 reference

21 December 2017

author name string

Valgeir Thorvaldsson

series ordinal

1

1 reference

21 December 2017

Arto Nordlund

series ordinal

2

1 reference

21 December 2017

Anders Wallin

series ordinal

6

1 reference

21 December 2017

publication date

26 March 2010

1 reference

21 December 2017

International Psychogeriatrics

published in

1 reference

21 December 2017

volume

22

1 reference

21 December 2017

issue

4

1 reference

21 December 2017

page(s)

598-606

1 reference

21 December 2017

Effects of age, sex, and ethnicity on the association between apolipoprotein E genotype and Alzheimer disease. A meta-analysis. APOE and Alzheimer Disease Meta Analysis Consortium

cites work

1 reference

https://api.crossref.org/works/10.1017%2FS1041610210000335

Impact of APOE in mild cognitive impairment

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1041610210000335

Mild cognitive impairment--beyond controversies, towards a consensus: report of the International Working Group on Mild Cognitive Impairment

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1041610210000335

Cognitive change and the APOE epsilon 4 allele

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1041610210000335

APOE status and its association to learning and memory performance in middle aged and older Norwegians seeking assessment for memory deficits

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1041610210000335

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1041610210000335

Stepwise comparative status analysis (STEP): a tool for identification of regional brain syndromes in dementia

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1041610210000335

Amyloid mediates the association of apolipoprotein E e4 allele to cognitive function in older people

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1041610210000335

CSF Abeta 42 levels correlate with amyloid-neuropathology in a population-based autopsy study

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1041610210000335

Cerebrospinal fluid beta-amyloid(1-42) in Alzheimer disease: differences between early- and late-onset Alzheimer disease and stability during the course of disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1041610210000335

Associations between white matter lesions, cerebrovascular risk factors, and low CSF Abeta42.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1041610210000335

Mild cognitive impairment and dementia

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1041610210000335

Bedside assessment of executive cognitive impairment: the executive interview

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1041610210000335

Working memory and apolipoprotein E: what's the connection?

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1041610210000335

The association between APOE genotype and memory dysfunction in subjects with mild cognitive impairment is related to age and Alzheimer pathology.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1041610210000335

The Goteborg MCI study: mild cognitive impairment is a heterogeneous condition

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1041610210000335

The influence of APOE status on episodic and semantic memory: data from a population-based study

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1041610210000335

Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1041610210000335

Apolipoprotein E4: a causative factor and therapeutic target in neuropathology, including Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1041610210000335

Apolipoprotein E is not related to memory abilities at 70 years of age.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1041610210000335

APOE genotype and cognitive functioning in a large age-stratified population sample.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1041610210000335

Change in cognitive functioning associated with apoE genotype in a community sample of older adults.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1041610210000335

The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1041610210000335

Association between CSF biomarkers and incipient Alzheimer's disease in patients with mild cognitive impairment: a follow-up study

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1041610210000335

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1041610210000335

Factorial Invariance and The Specification of Second-Order Latent Growth Models

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1041610210000335

Comparative fit indexes in structural models

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1041610210000335

No association between the α2-macroglobulin (A2M) deletion and Alzheimer's disease, and no change in A2M mRNA, protein, or protein expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1041610210000335

Structural Model Evaluation and Modification: An Interval Estimation Approach

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1041610210000335

7 January 2021

Clinical dementia rating: a reliable and valid diagnostic and staging measure for dementia of the Alzheimer type.

1 reference

https://api.crossref.org/works/10.1017%2FS1041610210000335

7 January 2021

Test-retest reliability of a new form of the auditory verbal learning test (AVLT).

1 reference

https://api.crossref.org/works/10.1017%2FS1041610210000335

7 January 2021

Neuropsychological function and apolipoprotein E genotype in the preclinical detection of Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1017%2FS1041610210000335

7 January 2021

10.1017/S1041610210000335

Identifiers

DOI

1 reference

21 December 2017

1 reference

21 December 2017